Whole genomes define concordance of matched primary, xenograft, and organoid models of pancreas cancer.
Pancreatic ductal adenocarcinoma (PDAC) has the worst prognosis among solid malignancies and improved therapeutic strategies are needed to improve outcomes. Patient-derived xenografts (PDX) and patient-derived organoids (PDO) serve as promising tools to identify new drugs with therapeutic potential...
| 出版年: | PLoS Computational Biology |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , , , |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
Public Library of Science (PLoS)
2019-01-01
|
| オンライン・アクセス: | https://doi.org/10.1371/journal.pcbi.1006596 |
